MLYS
Mineralys Therapeutics Inc
$8.76M
Single buy
Discretionary Insider Activity
Date:
03/27/2026
Insiders:
RA CAPITAL MANAGEMENT, L.P., director
Prior trend:
17 weeks of no discretionary insider activity

Summary

A $8.76M single buy for Mineralys Therapeutics Inc (MLYS) on 03/27/2026 after 17 weeks of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Buy $8.76M 03/31/2026 RA CAPITAL MANAGEMENT, L.P. + 3 Director 0001231919-26-000300

Stake Changes

Action Insider Role(s) Total Change % Change
RA CAPITAL MANAGEMENT, L.P. Director unknown unknown

Transactions

Action Amount Date Insider Security Type SEC Code
Buy $7.35M 03/27/2026 RA CAPITAL MANAGEMENT, L.P. Common Stock Discretionary Purchase
Buy $1.41M 03/30/2026 RA CAPITAL MANAGEMENT, L.P. Common Stock Discretionary Purchase

Metadata

Signal ID:
VEaidZ6Eld3HhosL
Scanned on:
04/01/2026
Status:
Current